2014-11-14T14:07:58-06:00 2014-06-30 GRANT THORNTON LLP 175 W JACKSON BLVD STE 2000 CHICAGO IL 60604 990 2013-07-01 133039601 Alzheimer's Disease & Related Disorders Association Inc % RICHARD HOVLAND COO/CFO ALZH 3123358700 225 N Michigan Ave Suite 17th Flr Chicago IL 606017633 RICHARD H HOVLAND COO/CFO 3123358700 2014-11-12 true Bridget T Roche P00666837 3123358700 2013 2015-11-30 17:44:51Z Alzheimer's Association Richard Hovland 225 N Michigan Ave Chicago IL 606017633 165739045 false 9334 X www.alz.org X 1980 IL Eliminate Alzheimer's disease through the advancement of research, provide & enhance care & support for all aff- ected & reduce the risk of dementia through promotion of brain health. 39 39 595 5556 0 108946787 120547521 3589556 4350928 2271114 2334371 4223272 3965656 119030729 131198476 16736969 15601943 0 0 35949146 45312720 140283 142353 20070258 56795873 61593597 109622271 122650613 9408458 8547863 138486960 161616574 53897965 56911456 84588995 104705118 X THE ALZHEIMER'S ASSOCIATION IS THE WORLD'S LEADING VOLUNTARY HEALTH ORGANIZATION IN ALZHEIMER CARE, SUPPORT, AND RESEARCH. THE MISSION OF THE ALZHEIMER'S ASSOCIATION IS TO ELIMINATE ALZHEIMER'S DISEASE THROUGH THE ADVANCEMENT OF RESEARCH; TO PROVIDE AND ENHANCE CARE AND SUPPORT FOR ALL AFFECTED; AND TO REDUCE THE RISK OF DEMENTIA THROUGH THE PROMOTION OF BRAIN HEALTH. THE VISION: A WORLD WITHOUT ALZHEIMER'S. THE ALZHEIMER'S ASSOCIATION IS A VALUED RESOURCE FOR CAREGIVERS AND THOSE LIVING WITH THE DISEASE, OFFERING INFORMATION, EDUCATION AND SUPPORT. THE ALZHEIMER'S ASSOCIATION HAS 80 CHAPTERS WORKING TOGETHER TO ACCOMPLISH THE MISSION. THE NATIONAL ORGANIZATION IS HEADQUARTERED IN CHICAGO, AND HAS A PUBLIC POLICY OFFICE IN WASHINGTON, D.C. THE ALZHEIMER'S ASSOCIATION PROVIDES 24/7 CONSTITUENT SUPPORT THROUGH A HELPLINE 365 DAYS A YEAR (1.800.272.3900) AND AN AWARD-WINNING WEB SITE, ALZ.ORG. THE ALZHEIMER'S ASSOCIATION IS THE WORLD'S LEADING VOLUNTARY HEALTH ORGANIZATION IN CARE, SUPPOR false false 31237270 198298 165913 Public Awareness and Education - Alzheimer's is a progressive, degenerative and ultimately fatal disease. Too few Americans understand the current and future economic impact of Alzheimer's. Already more than 5 million Americans are living with Alzheimer's and more than 15 million people are providing unpaid care and support. And this massive group is in need of information and resources. The Alzheimer's Association has invested in education campaigns and initiatives to increase knowledge about Alzheimer's disease and awareness of the Alzheimer's Association as the center of help and hope. Key messages include the importance of early detection, resources for people with Alzheimer's and their families, and the societal impact of the disease. Millions of constituents are engaged to educate their communities and workplaces. 26275358 13269287 3972383 Research - The Alzheimer's Association is on the forefront of the Alzheimer's scientific field, globally connecting researchers in the quest to find methods of treatment, prevention and a cure. The Alzheimer's Association implements an aggressive global research and science program strategically designed to accelerate progress by fostering innovation, identifying and filling critical knowledge gaps, developing and disseminating tools, and nurturing scientific talent. The Alzheimer's Association has been a catalyst and convener for more than 30 years. Whether funding innovative grants to help further treatments and discovery, hosting the Alzheimer's Association International Conference (AAIC*), the world's largest gathering of Alzheimer's researchers, or leading the Worldwide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI) to accelerate advances in imaging, the Alzheimer's Association seeks to fund and advance best-in-class research and works with collaborators around the globe from all sectors to hasten this progress. * These are names that are trademarks to Alzheimer's Association 10801005 677819 378545 Chapter Services - From coast to coast, 80 chapters are in communities nationwide, providing services to families and professionals, including information and referral, support groups, care consultation, education and safety services. The national organization provides strategic, tactical, and direct support in these activities. 26946217 1456539 95259850 true true false true false false false false false true true true false false true true false true false false true true false true true true false true false true false false false false false false false false true false false false false true true true true false true 175 0 true 595 true false false false false false true true false false false false X 39 39 false false false false false false false true true false true true true true true true true true true true false AL AK AR CA CT DC FL GA HI ID IL IN KS KY LA ME MD MA MI MN MS MT NE NV NH NJ NM NY NC OK OR PA RI SC TN TX UT VT VA WV WI WY X X RICHARD HOVLAND COOCFO 3123355771 225 N MICHIGAN AVENUE Chicago IL 606017633 Gerald Sampson Chair, Exec. Comm., Director 10.0 X X 0 0 0 Stewart Putnam Chair Elect, Exec. Comm., Dir. 10.0 X X 0 0 0 Deborah Jones Secretary, Exec. Comm., Dir. 10.0 X X 0 0 0 Thomas J Winkel Treasurer, Exec. Comm., Dir. 10.0 X X 0 0 0 Christopher Binkley Director and Exec Committee 5.0 X 0 0 0 Bill Buechele Director and Exec Committee 5.0 X 0 0 0 Jack Faer Director and Exec Committee 5.0 X 0 0 0 Marlana Geha PhD Director and Exec Committee 5.0 X 0 0 0 Louis Holland Jr Director and Exec Committee 5.0 X 0 0 0 Jacqueline Kouri Director and Exec Committee 5.0 X 0 0 0 Ralph A Nixon MD PhD Director and Exec Committee 5.0 X 0 0 0 Margaret Noel MD Director and Exec Committee 5.0 X 0 0 0 Ronald Petersen MD PhD Director and Exec Committee 5.0 X 0 0 0 Kimberly Reed Director and Exec Committee 5.0 X 0 0 0 Carl E Tuerk Jr Director and Exec Committee 5.0 X 0 0 0 Electra Anderson Director 5.0 X 0 0 0 Robert K Burke Director 5.0 X 0 0 0 Laurie Burrows Grad Director 5.0 X 0 0 0 Anna C Catalano Director 5.0 X 0 0 0 Matthew Furman Director 5.0 X 0 0 0 Deborah Garrett Director 5.0 X 0 0 0 Elizabeth Gelfand Stearns Director 5.0 X 0 0 0 David Goltermann Director 5.0 X 0 0 0 James Grossmann Director 5.0 X 0 0 0 Verna Jones-Rodwell Director 5.0 X 0 0 0 Jeffrey Maloney Director 5.0 X 0 0 0 Joe McCafferty Director 5.0 X 0 0 0 David Moscow Director 5.0 X 0 0 0 Patrick Peyton Director 5.0 X 0 0 0 Deborah A Randall Esq Director 5.0 X 0 0 0 Brian Richardson Director 5.0 X 0 0 0 Scott Russell EdD Director 5.0 X 0 0 0 David Simbro Director 5.0 X 0 0 0 Alan Silverglat Director 5.0 X 0 0 0 Stan Thurston Director 5.0 X 0 0 0 Joan Uronis Director 5.0 X 0 0 0 Paul Wexler Director 5.0 X 0 0 0 R Thomas Bodkin Director (Thru 10/19/13) 5.0 X 0 0 0 Cathy Edge Director (Thru 10/19/13) 5.0 X 0 0 0 Karen Kauffman PhD CRNP BC Director (Thru 10/19/13) 5.0 X 0 0 0 John E Maggio PhD Director (Thru 10/19/13) 5.0 X 0 0 0 Suzanne B Swift Director (Thru 10/19/13) 5.0 X 0 0 0 Jerome H Stone Founding Pres, Honorary Chair 5.0 X 0 0 0 Bonnie Marcus Director (thru 10/19/13) 5.0 X Harry Johns President & CEO 60.0 1.7 X 748885 36360 265928 Richard Hovland COO/CFO 60.0 0.1 X 494155 502 94374 Angela Geiger Chief Strategy Officer 60.0 0.1 X 473506 1444 100555 Maria Carrillo VP Med & Scientific Relations 60.0 X 317132 0 33124 Robert Egge VP - Public Policy 60.0 2.0 X 315795 18760 55617 Scott Gardner VP - Chapter Relations 60.0 0.1 X 277252 294 40297 Paula Pelissero Sr. Director, Human Resources 55.0 X 223901 0 8503 Donna McCullough VP - Mass Market & Corp Dev 60.0 X 275685 0 33784 3126311 57360 632182 75 false true false Olson Co Inc 420 North Fifth St Ste 1000 MINNEAPOLIS MN 55401 Advertising 14980660 Alaniz 425 N Iris Street MT PLEASANT IA 52641 Print/Letter Shop 6235068 Web Mason PO Box 62414 BALTIMORE MD 21264 Print/Letter Shop 2301010 Michigan Avenue Plaza PO Box 88181 Expedite Way CHICAGO IL 60695 Realtor 1851503 RR Donnelly PO Box 93514 CHICAGO IL 60673 Print/Letter Shop 1664785 102 249175 1051886 2903377 116343083 5225166 120547521 PROGRAM CONFERENCES 611710 3823270 3823270 JOURNAL 511120 149113 149113 SAFE RETURN REGISTRATION FEES 611710 172513 172513 CAREGIVER TRAINING 611710 206032 206032 4350928 2044612 2044612 0 44893 44893 0 0 0 32458884 0 32167054 2071 291830 -2071 289759 289759 3565630 1051886 1671846 1893784 1893784 53322 7256 46066 46066 933495 692342 241153 165913 75240 AFFILIATE REVENUE 900099 1176221 1176221 CHAPTER LICENSING AND MAINTENANCE 900099 547650 547650 OTHER REVENUE 900099 15889 15889 1739760 131198476 4516841 6134114 13891406 13891406 0 1710537 1710537 0 2194206 1322619 350115 521472 0 34438947 25318718 1786009 7334220 5133070 3819366 242915 1070789 3424668 2583094 227336 614238 121829 89172 8589 24068 0 687821 411531 27524 248766 126100 101587 12031 12482 336000 336000 142353 142353 119600 119600 8908065 5210976 1033614 2663475 14499450 14158434 77153 263863 19597729 12072339 2949412 4575978 651785 552292 32854 66639 0 6953998 6026452 224943 702603 6786539 5172987 207099 1406453 0 1222289 1024077 52692 145520 0 0 1141592 916700 76528 148364 177483 153897 3383 20203 . . . . 385146 268066 8308 108772 122650613 95259850 7320505 20070258 X 14226605 8646762 2043933 3535910 0 0 20099316 29835931 16003666 28737753 26978835 15467687 0 0 0 0 947586 40000 303947 415792 6372636 4623058 21823890 14149065 5807081 7674825 47313443 54288980 14660450 20532548 0 0 0 0 0 0 138486960 161616574 7485089 9555088 23356557 21885412 2795357 3183375 0 0 0 0 0 0 0 0 0 0 20260962 22287581 53897965 56911456 X 34866162 39687770 24811186 37497269 24911647 27520079 84588995 104705118 138486960 161616574 X 8547863 4630720 3 6937537 X false true X true true true X 75626278 85472068 91869920 107906015 120547521 481421802 0 0 75626278 85472068 91869920 107906015 120547521 481421802 9634871 471786931 1969538 2154572 2076055 2376737 2089505 10666407 0 2610156 4921675 6683529 5918160 6103829 26237349 518325558 21837490 0.91021 0.90928 X 0.00000 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true true 127951 true 3000 true 13000 false true 941385 true 759461 false 1844797 false Schedule C, Part II-B, Line 1a VOLUNTEERS Most of the Association's lobbying is through volunteers. Additionally the association has training to develop and organize chapter based grassroots activities. For fiscal year 2014 these training expenditures were $352,773. As Alzheimer's disease and related dementias, hereafter referred to as Alzheimer's disease, threaten to bankrupt families, businesses and the healthcare system, scientists are moving closer to finding better treatments that could alter the course of the disease. The Alzheimer's Association advocates for public policies aimed at advancing research toward better therapies, detection, methods of prevention and ultimately a cure, as well as for high quality healthcare and long term services and support for people with Alzheimer's and their families. This includes advocacy for better care for people and families already facing Alzheimer's. Advocacy activities also include collaborating with other organizations to improve quality care and raise awareness of key issues. Schedule C, Part II-B, Line 1c MEDIA ADVERTISEMENTS Media advertisements were run during the Advocacy Forum. Schedule C, Part II-B, Line 1d MAILING TO MEMBERS, LEGISLATORS OR THE PUBLIC Mailing costs to distribute Facts and Figures to legislators. Schedule C, Part II-B, Line 1e PUBLICATIONS, OR PUBLISHED OR BROADCAST STATEMENTS The Association distributed Federal and State Updates approximately 26 times during the year. Schedule C, Part II-B, Line 1g DIRECT CONTACT The Association utilized Appropriation Consultants to make direct contact with legislators. 12654952 1060152 1961725 1961725 13715104 11611486 333853 709613 12654952 11255752 323701 32033 11611486 9438167 632021 1185564 11255752 8125409 117211 1195547 9438167 0.94597 0.05403 false false 160000 160000 440000 22564 417436 4234285 2922951 1311334 7150705 5485859 1664846 9838900 5717691 4121209 7674825 BENEFICIAL INTERESTS 20310202 F ASSETS HELD IN TRUST 222346 F 20532548 0 DUE TO CHAPTERS 15183396 GIFT ANNUITY OBLIGATIONS 5049478 DEFFERED RENT 1682361 DEFFERED COMPENSATION 372346 22287581 X 141154264 4630720 3338292 1294434 9263446 131890818 -692342 -692342 131198476 127201633 3338292 1212728 4551020 122650613 122650613 Schedule D, Part V, Line 4 INTENDED USES OF ENDOWMENT FUNDS Permanently restricted net assets are restricted as investments in perpetuity. The Association's endowment only consists of donor-restricted endowment funds. Net assets associated with the Association's endowment funds are classified and reported based on the existence of donor-imposed restrictions. Donors restrict the earnings of some of the Association's endowment funds to fund the Association's research program. In accordance with donor stipulations, the income generated from these assets is restricted for research (approximately 48%) or not purpose restricted (approximately 52%). The Association accounts for endowment net assets by preserving the fair value of the original gift as of the gift date of the donor-restricted endowment fund absent explicit donor stipulations to the contrary. As a result, the Association classifies as permanently restricted net assets (1) the original value of gifts donated to the permanent endowment, (2) the original value of subsequent gifts to the permanent endowment and (3) accumulations to the permanent endowment made in accordance with the direction of the applicable donor gift instrument at the time the accumulation is added to the endowment fund. The Association considers the following factors in making a determination to appropriate or accumulate donor-restricted endowment funds: - The duration and preservation of the fund. - The purposes of the Association and the donor-restricted endowment fund. - General economic conditions. - The possible effects of inflation and deflation. - The expected total return from income and the appreciation of investments. - Other resources of the Association. - The investment policies of the Association. The Association has adopted an investment policy that attempts to provide a predictable stream of funding to programs supported by its endowment while seeking to maintain the purchasing power of the endowment assets. As of June 30, 2014, endowment assets only include those assets of donor-restricted funds that the Association must hold in perpetuity, as the Association does not have any board-designated endowment funds. Under this policy, as approved by the board of directors, the endowment assets are invested in a manner that is intended to provide adequate liquidity, maximizing returns on all funds invested and achieving full employment of all available funds as earning assets. The Association has an active finance committee and investment sub-committee that meets regularly to ensure that the objectives of the investment policy are met, and that the strategies used to meet the objectives are in accordance with the investment policy. The Association's policy is to appropriate spending amounts deemed prudent for donor-restricted funds. SCHEDULE D, PART X, LINE 2 FIN 48 The Association and Alzheimer's Impact Movement (AIM) have received favorable determination letters from the Internal Revenue Service, stating that they are exempt from federal income taxes under the provisions of Section 501(a) of the Internal Revenue Code of 1986 (IRC), as organizations described in Sections 501(c)(3) and 501(c)(4), respectively, except for income taxes pertaining to unrelated business income. Alzheimer's Impact Movement Political Activity Committee (AIMPAC) is a political action committee organization exempt from federal taxes under Section 527 of the IRC. The Financial Accounting Standards Board issued guidance that requires tax effects from uncertain tax positions to be recognized in the consolidated financial statements only if the position is more likely than not to be sustained if the position were to be challenged by a taxing authority. Management has determined there are no material uncertain positions that require recognition in the consolidated financial statements and, as such, no provision for income taxes is reflected. Additionally, there is no interest or penalties recognized in the consolidated statements of activities or statements of financial position. Aside from the current year, the tax years ended 2010, 2011, 2012 and 2013 are still open to audit for both federal and state purposes. Schedule D, Part XI, Line 2D RECONCILIATION OF REVENUE Change in perpetual trust $1,548,279 Change in split interest (253,845) TOTAL $1,294,434 Schedule D, Part XI, Line 4B RECONCILIATION OF REVENUE Cost Of Goods Sold $(692,342) TOTAL $(692,342) Schedule D, Part XII, Line 2D RECONCILIATION OF EXPENSES Cost of goods sold $692,342 Bad debt $520,386 TOTAL $1,212,728 true North America Program Services Grantmaking 198956 Europe (Including Iceland and Greenland) Program Services Grantmaking 1175201 East Asia and the Pacific Program Services Grantmaking 336380 1710537 1710537 Europe (Including Iceland and Greenland) Program Support 100000 Check or WT FMV North America Program Support 99958 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 100000 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 99971 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 195654 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 243952 Check or WT FMV East Asia and the Pacific Program Support 98780 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 98119 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 95700 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 98805 Check or WT FMV North America Program Support 98998 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 100000 Check or WT FMV East Asia and the Pacific Program Support 237600 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 43000 Check or WT FMV 14 0 false false false false false false Schedule F, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS OUTSIDE U.S. The over-sight of the scientific integrity of the Alzheimer's Association International Research Grant Program is three-fold. First, the Alzheimer's Association voluntary Medical & Scientific Advisory Council ensures peer review and high quality of funded awards during the grant review process and develops focused requests for applications (RFAs) based on identified needs in the Alzheimer research community. Second, the Alzheimer's Association is engaged in a portfolio analysis of scientific areas of investment to monitor the diversity of the grants portfolio, potential gaps in research funding, and potential overlap of areas funded. The analysis informs future funding decisions and areas of RFA focus. Third, there is a detailed process once a grant is awarded to monitor program and scientific and financial integrity. The Alzheimer's Association monitors the use of grant funds both inside and outside of the United States as follows: All awardees are required to provide annual reporting to the Alzheimer's Association on both the status of the research project and financial expenditures associated with the award. Sixty days prior to the anniversary of the award, an Alzheimer's Association Post-Award Specialist notifies all researchers and all designated institutional financial officials with fiscal responsibility for the award of the required reports, which include an interim scientific report, and interim financial report and documentation of any publications as a result of Association funding. The institutional official who has fiscal responsibility for the award cannot be the primary investigator of the project. The Alzheimer's Association provides a template for the interim scientific report and a template for the interim financial report, both of which are available for download by the researchers as well as the official with fiscal responsibility for the grant at the awarded institution at https://proposalcentral.altum.com/login.asp. The financial report must be signed by the institutional official with fiscal responsibility, and all reports must be uploaded by the award recipient to ProposalCentral. After receipt, all financial reports are reviewed by an Alzheimer's Association Post-Award Specialist for accuracy and consistency with the agreed upon budget. In addition, the Association required protocol continuation approval (i.e., IACUC, IRB, RDNA) annually, if applicable to the research project. Any subsequent payments to grant awardees are generated after their receipt and approval by the Vice President of Medical and Scientific Relations. At the conclusion of the award, all reports/publication(s) are due 90 days after the award expires and must be uploaded to ProposalCentral online system. The financial report must be signed by the institutional official who has fiscal responsibility for the award. In addition, the association requests, monitors, and follows-up to ensure submission compliance on all awarded contracts and that financial reporting requirements are met. Awardees' financial reports are audited annually to ensure eligibility for continued funding. Delinquent report(s) may result in the withdrawal of funding. Researchers are informed that delinquent reporting could lead to withdrawal of funding when the request for annual report(s) is sent. If funding is withdrawn due to delinquent reports, any unspent funds must be returned to the Alzheimer's Association. This Researcher becomes ineligible to apply for funding from the Alzheimer's Association. Foreign institutions are required to submit one of the following as verification of non-profit status: * Organization's charter, bylaws and other governing documents * Documentation of non-profit designation from organization's government For-profit organizations are not eligible to apply to the Alzheimer's Association's International Research Grant Program, with the exception of the Part the Cloud Translational Research Grant Program. All institutions are required to submit verification of their non-profit status dated within the last five years (e.g., IRS tax determination letter). If their determination letter is dated prior to this five year period, the institution is asked to provide documentation from an authorized organization individual to confirm there has not been a status change for the organization. For the Part the Cloud Translational Research Grant Program, any for-profit applicant is required to submit their financial statements. Prior to award confirmation, the Medical and Scientific Department verifies that each awardee is compliant with federal laws and does not appear on the Specially Designated Nationals (SDN) lists. For transactions unrelated to the International Research Grant Program in the Medical and Scientific Department, the same verification is performed. The Alzheimer's Association monitors the scientific advances of the Association's grant awardees by maintaining records of publications, presentations, and intellectual property that result from funded studies. The Association requires the grant recipient to notify the Alzheimer's Association on an annual basis with updates to these records. Follow-on funding from federal agencies is also monitored. X X X X X X X true THD DM Outrch PUSH E-MAIL false 42333243 1050981 41282212 Infocision Aware Vol Program false 570809 43083 527726 42904052 1094064 41809938 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY NY Gala 1100146 287146 813000 155146 241502 145529 Sardi's 1119191 403491 715700 194241 135428 109921 19 2398179 361249 2036930 67319 34072 288516 300172 4617516 1051886 3565630 416706 34072 665446 555622 1671846 1893784 53322 0 7256 0 0 false 53322 0 7256 0 0 7256 46066 IL IA NE true false true false 1.00000 Michelle Helton 225 N Michigan Ave 17th Flr Chicago IL 606017633 false Lynne Carey 600 Overall supervision and management X false Schedule G, Part I, Line 2B, Box (III) FUNDRAISING CONSULTANT - CONTROL ARRANGEMENT The Alzheimer's Association is no longer engaged with Infocision Management Corporation (IMC) for professional fundraising consultant services. The contract has ended and the Alzheimer's Association did not renew the contract. The Alzheimer's Association engages Thompson, Habib & Denison, Inc. (THD) for professional fundraising consultant services. A description of the arrangement is listed below: Direct Marketing Strategy and Program Direction; Production Management; Database management; E-Mail Program Management; Budgeting Management; Report Management. Schedule G, Part I, Line 2B, Box (VI) FUNDRAISING CONSULTANT - FEE ARRANGEMENT The agreement between Thompson, Habib & Denison (THD) and the Alzheimer's Association is not a percentage-based agreement. THD is paid a fixed fee per month. The Alzheimer's Association exercises control and approval over the content and frequency of all solicitations. SCHEDULE G, PART III, LINE 11 ORGANIZATION OPERATES GAMING ACTIVITIES WITH NONMEMBERS The Alzheimer's Association is not a membership organization as described by the IRS. The organization, therefore, does not consider its donors members. As such, the organization has checked Box 11 in Part II of Schedule G "Yes". SCHEDULE G, PART III, LINE 16 ADDITIONAL GAMING MANAGER INFORMATION Name: Kate Levy Gaming manager compensation: $300 Description of services provided: Recordkeeping Employee Name: Katherine Lee Gaming manager compensation: $300 Description of services provided: Cash management and bank deposits Employee true Yale University 295 Congress Ave New Haven CT 06536 060646973 501(c)(3) 450000 FMV Program Support Trustees of Boston University 715 Albany St Boston MA 02118 104210354 501(c)(3) 450000 FMV Program Support New York University School of Medicine One Park Ave NY NY 10016 135562308 501(c)(3) 450000 FMV Program Support University of Illinois Chicago 809 S Marshfield Ave Chgo IL 60612 362174823 501(c)(3) 450000 FMV Program Support University of Wisconsin Madison 600 Highland Ave Madison WI 53792 396006492 501(c)(3) 100000 FMV Program Support University of Pittsburgh 3025 E Carson St Pittsburgh PA 15203 250965591 501(c)(3) 149998 FMV Program Support Case Western Reserve University 10900 Euclid Ave Cleveland OH 44106 341018992 501(c)(3) 100000 FMV Program Support Rush University Medical Ctr 1645 W Jackson Blvd Western Road Chgo IL 60612 362174823 501(c)(3) 99914 FMV Program Support University of California San Francisco 3333 Calif St 845 Sherbrooke St W James Admin B San Francisco CA 94143 946036493 501(c)(3) 100000 FMV Program Support Baylor College of Medicine 1250 Moursund St Houston TX 77030 174161378 501(c)(3) 100000 FMV Program Support Mayo Clinic Jacksonville 4500 San Pablo Rd Jacksonville FL 32224 159333702 501(c)(3) 99999 FMV Program Support Mayo Clinic Jacksonville 4500 San Pablo Rd Jacksonville FL 32224 159333702 501(c)(3) 100000 FMV Program Support Icahn School of Medicine at Mount Sinai 1 Gustave Levy Pl NY NY 10029 136171197 501(c)(3) 100000 FMV Program Support University of Texas at Austin 101 E 27th St Austin TX 78712 746000203 501(c)(3) 100000 FMV Program Support Georgetown University Harris Bldg Ste 1100 Wash DC 20007 530196603 501(c)(3) 99931 FMV Program Support Washington University in St Louis 425 S Euclid Ave St Louis MO 63110 431653611 501(c)(3) 100000 FMV Program Support University of Utah 10 S 2000 E Salt Lake City UT 84112 876000525 501(c)(3) 99999 FMV Program Support University of Washington 4333 Brooklyn Ave NE Seattle WA 98195 916001537 501(c)(3) 99946 FMV Program Support University of Michigan 1301 Catherine St Ann Arbor MI 48109 386006309 501(c)(3) 99839 FMV Program Support Bedford VA Research Corp 150 S Huntington Ave Boston MA 02130 043512440 501(c)(3) 99954 FMV Program Support Case Western Reserve University 10900 Euclid Ave Cleveland OH 44106 341018992 501(c)(3) 100000 FMV Program Support Rutgers 195 University Ave Newark NJ 07102 226001086 501(c)(3) 100000 FMV Program Support The University of California at Irvine 5171 Calif Ave Irvine CA 92697 952226406 501(c)(3) 244194 FMV Program Support The University of Alabama 1720 2nd Ave S Birmingham AL 35294 163600539 501(c)(3) 245151 FMV Program Support University of Miami 1320 S Dixie Hghy Coral Gables FL 33146 590614458 501(c)(3) 244498 FMV Program Support Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 340714585 501(c)(3) 243952 FMV Program Support Boston University 85 East Newton St Boston MA 02118 104210354 501(c)(3) 243881 FMV Program Support Brigham and Women's Hospital 75 Francis St Boston MA 02115 104231290 501(c)(3) 244109 FMV Program Support University of Calif - San Francisco 3333 Calif St San Francisco CA 94143 946036493 501(c)(3) 245152 FMV Program Support Beth Israel Deaconess Medical 330 Brookline Ave Boston MA 02215 042103881 501(c)(3) 243951 FMV Program Support Joslin Diabetes Center One Joslin Place Boston MA 02215 042203836 501(c)(3) 243955 FMV Program Support University of Pittsburgh 123 University Pl Pittsburgh PA 15213 250965591 501(c)(3) 245152 FMV Program Support University of California San Diego 9500 Gilman Dr La Jolla CA 92093 956006144 501(c)(3) 241138 FMV Program Support Boston University 85 East Newton St Boston MA 02118 104210354 501(c)(3) 243441 FMV Program Support Yale University 47 College St New Haven CT 06520 060646973 501(c)(3) 243952 FMV Program Support Medical University of S Carolina 19 Hagood Ave Charleston SC 29425 576000722 501(c)(3) 243542 FMV Program Support Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 340714585 501(c)(3) 166393 FMV Program Support Icahn School of Medicine at Mt Sinai 1 Gustave Levy Pl NY NY 10029 136171197 501(c)(3) 166096 FMV Program Support Nathan Kline Institute 140 Old Orangeburg Rd Orangeburg NY 10962 141410842 501(c)(3) 98738 FMV Program Support University of Rochester 518 Hylan Bldg Rochester NY 14627 160743209 501(c)(3) 98780 FMV Program Support Cornell University 373 Pine Tree Rd Ithaca NY 14850 150532082 501(c)(3) 98760 FMV Program Support University of Washington 4333 Brooklyn Ave NE Seattle WA 98195 916001537 501(c)(3) 98780 FMV Program Support University of NC Chapel Hill 104 Airport Dr Chapel Hill NC 27599 566001393 501(c)(3) 98506 FMV Program Support University of Michigan 3003 S State St Ann Arbor MI 48109 386006309 501(c)(3) 98515 FMV Program Support Sun Health Research Institute 10515 W Santa Fe Dr Sun City AZ 85351 450233470 501(c)(3) 98732 FMV Program Support University of North Texas at Fort Worth 3500 Camp Bowie Blvd Ft Worth TX 76107 756064033 501(c)(3) 98780 FMV Program Support Rutgers 3 Rutgers Pl New Brunswick NJ 08901 226001086 501(c)(3) 98780 FMV Program Support Barrow Neurological Institute 350 W Thomas Rd Phoenix AZ 85013 860096787 501(c)(3) 98780 FMV Program Support University of California - San Diego 9500 Gilman Dr La Jolla CA 92093 956006144 501(c)(3) 98780 FMV Program Support University of Oklahoma Svc Center Bldg Okla City OK 73126 736017987 501(c)(3) 98853 FMV Program Support Roskamp Institute 2040 Whitfield Ave Sarasota FL 34243 271397124 501(c)(3) 98805 FMV Program Support Brandeis University 415 South St Waltham MA 02454 042103552 501(c)(3) 98781 FMV Program Support Indiana University 980 Indiana Ave Indianapolis IN 46202 356001673 501(c)(3) 98874 FMV Program Support University of Kentucky 500 S Limestone Lexington KY 40526 616033693 501(c)(3) 98966 FMV Program Support University of Texas Southwestern 5323 Harry Hines Rd Dallas TX 75390 175600286 501(c)(3) 98640 FMV Program Support Tufts Medical Center 800 Washington St Boston MA 02111 043400617 501(c)(3) 98779 FMV Program Support Medical Center Columbia University 630 W 168th St NY NY 10032 135598093 501(c)(3) 98756 FMV Program Support American Brain Foundation 203 Chicago Ave Minneapolis MN 55415 430653611 501(c)(3) 43333 FMV Program Support University of California San Francisco 3333 Calif St San Francisco CA 94143 946036493 501(c)(3) 212419 FMV Program Support University of Southern California 3720 S Flower St Los Angeles CA 90089 951642394 501(c)(3) 457000 FMV Program Support Gladstone Institute 1650 Owens St San Francisco CA 94158 123702366 501(c)(3) 240000 FMV Program Support Foundation for the National Institute of Health 9650 Rockville Pike Bethesda MD 20814 521986675 501(c)(3) 650000 FMV Program Support Reagan Udall Foundation 800 I St NW Wash DC 20001 263727917 501(c)(3) 205991 FMV Program Support National Biomedical Research 3108 Skipworth Dr Las Vegas NV 89107 352462963 501(c)(3) 100000 FMV Program Support University of Miami 1320 S Dixie Hghy Coral Gables FL 33146 590624458 501(c)(3) 25000 FMV Program Support Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 340714585 501(c)(3) 46666 FMV Program Support Case Western University 10900 Euclid Ave Cleveland OH 44106 341018992 501(c)(3) 80000 FMV Program Support Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 340714585 501(c)(3) 46666 FMV Program Support Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 340714585 501(c)(3) 46666 FMV Program Support University of Southern California 3720 S Flower St Los Angeles CA 90089 951642394 501(c)(3) 457000 FMV Program Support Cleveland Clinic Foundation 9500 Euclid Ave Cleveland OH 44195 340714585 501(c)(3) 99983 FMV Program Support University of Pennsylvania 3451 Walnut St Philadelphia PA 19104 231352685 501(c)(3) 67889 FMV Program Support California Southland Chapter 4221 Wilshire Blvd Los Angeles CA 90010 953718119 501(c)(3) 63255 FMV Program Support Central Ohio Chapter 1379 Dublin Road Columbus OH 43215 310996236 501(c)(3) 11375 FMV Program Support Colorado Chapter 455 Sherman St Denver CO 80203 840908354 501(c)(3) 13435 FMV Program Support Delaware Valley Chapter 399 Market St Phila PA 19106 232280056 501(c)(3) 16775 FMV Program Support Desert Southwest Chapter 1028 East McDowell Rd Phoenix AZ 85006 860402582 501(c)(3) 13840 FMV Program Support Florida Gulf Coast Chapter 14010 Roosevelt Blvd Clearwater FL 33762 592378435 501(c)(3) 12055 FMV Program Support Georgia Chapter 41 Perimeter Ctr E Atlanta GA 30346 581492046 501(c)(3) 21575 FMV Program Support Greater Illinois Chapter 8430 W Bryn Mawr Chgo IL 60631 363102348 501(c)(3) 6515 FMV Program Support Greater Indiana Chapter 50 East 91st St Indianapolis IN 46240 351747836 501(c)(3) 14245 FMV Program Support Greater Maryland Chapter 1850 York Road Timonium MD 21093 521219428 501(c)(3) 13240 FMV Program Support Greater Cincinnati Chapter 644 Linn St Cincinnati OH 45203 311067991 501(c)(3) 12315 FMV Program Support Greater Pennsylvania Chapter 2595 Interstate Dr Harrisburg PA 17110 251510692 501(c)(3) 19650 FMV Program Support Houston and Southeast Texas Chapter 2242 W Holcombe Houston TX 77030 742198685 501(c)(3) 13525 FMV Program Support Maine Chapter 383 US Route 1 Scarborough ME 04074 010428502 501(c)(3) 19150 FMV Program Support MassachusettsNew Hampshire Chapter 480 Pleasant St Watertown MA 02472 042731194 501(c)(3) 52614 FMV Program Support Miami Valley Chapter 31 Whipp Rd Dayton OH 45459 311031867 501(c)(3) 11515 FMV Program Support Michigan Great Lakes Chapter 310 N Main St Chelsea MI 48118 382380738 501(c)(3) 11770 FMV Program Support Mid South Chapter 4825 Trousdale Dr Nashville TN 37220 621860364 501(c)(3) 13150 FMV Program Support Minnesota North Dakota Chapter 7900 West 78th St Minneapolis MN 55426 411361624 501(c)(3) 22670 FMV Program Support National Capital Area Chapter 3701 Pender Dr Fairfax VA 22030 521196162 501(c)(3) 13045 FMV Program Support Northern California and Nevada Chapter 1060 La Avenida St Mtn View CA 94043 942897949 501(c)(3) 18550 FMV Program Support Southeastern Wisconsin Chapter 620 S 76th St Milwaukee WI 53214 391350965 501(c)(3) 13570 FMV Program Support St Louis Chapter 9370 Olive Blvd St Louis MO 63132 431237069 501(c)(3) 34835 FMV Program Support West Virginia Chapter 1601 2nd Ave Charleston WV 25387 363487172 501(c)(3) 11500 FMV Program Support Alzheimer's Impact Movement 225 N Michigan Ave Chgo IL 60601 271961435 501(c)(4) 1043725 FMV Program Support Program Support 96 1 Schedule I, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. The over-sight of the scientific integrity of the Alzheimer's Association International Research Grant Program is three-fold. First, the Alzheimer's Association voluntary Medical & Scientific Advisory Council ensures peer review and high quality of funded awards during the grant review process and develops focused requests for applications (RFAs) based on identified needs in the Alzheimer research community. Second, the Alzheimer's Association is engaged in a portfolio analysis of scientific areas of investment to monitor the diversity of the grants portfolio, potential gaps in research funding, and potential overlap of areas funded. The analysis informs future funding decisions and areas of RFA focus. Third, there is a detailed process once a grant is awarded to monitor program and scientific and financial integrity. The Alzheimer's Association monitors the use of grant funds both inside and outside of the United States as follows: All awardees are required to provide annual reporting to the Alzheimer's Association on both the status of the research project and financial expenditures associated with the award. Sixty days prior to the anniversary of the award, an Alzheimer's Association Post-Award Specialist notifies all researchers and all designated institutional financial officials with fiscal responsibility for the award of the required reports, which include an interim scientific report, and interim financial report and documentation of any publications as a result of Association funding. The institutional official who has fiscal responsibility for the award cannot be the primary investigator of the project. The Alzheimer's Association provides a template for the interim scientific report and a template for the interim financial report, both of which are available for download by the researchers as well as the official with fiscal responsibility for the grant at the awarded institution at https://proposalcentral.altum.com/login.asp. The financial report must be signed by the institutional official with fiscal responsibility, and all reports must be uploaded by the award recipient to ProposalCentral. After receipt, all financial reports are reviewed by an Alzheimer's Association Post-Award Specialist for accuracy and consistency with the agreed upon budget. In addition, the Association required protocol continuation approval (i.e., IACUC, IRB, RDNA) annually, if applicable to the research project. Any subsequent payments to grant awardees are generated after their receipt and approval by the Vice President of Medical and Scientific Relations. At the conclusion of the award, all reports/publication(s) are due 90 days after the award expires and must be uploaded to ProposalCentral online system. The Financial Report must be signed by the Institutional Official who has fiscal responsibility for the award. In addition, the association requests, monitors, and follows-up to ensure submission compliance on all awarded contracts and that financial reporting requirements are met. Awardees' financial reports are audited annually to ensure eligibility for continued funding. Delinquent report(s) may result in the withdrawal of funding. Researchers are informed that delinquent reporting could lead to withdrawal of funding when the request for annual report(s) is sent. If funding is withdrawn due to delinquent reports, any unspent funds must be returned to the Alzheimer's Association. This Researcher becomes ineligible to apply for funding from the Alzheimer's Association. Foreign institutions are required to submit one of the following as verification of non-profit status: * Organization's charter, bylaws and other governing documents * Documentation of non-profit designation from organization's government For-profit organizations are not eligible to apply to the Alzheimer's Association's International Research Grant Program, with the exception of the Part the Cloud Translational Research Grant Program. All institutions are required to submit verification of their non-profit status dated within the last five years (e.g., IRS tax determination letter). If their determination letter is dated prior to this five year period, the institution is asked to provide documentation from an authorized organization individual to confirm there has not been a status change for the organization. For the Part the Cloud Translational Research Grant Program, any for-profit applicant is required to submit their financial statements. Prior to award confirmation, the Medical and Scientific Department verifies that each awardee is compliant with federal laws and does not appear on the Specially Designated Nationals (SDN) lists. For transactions unrelated to the International Research Grant Program in the Medical and Scientific Department, the same verification is performed. The Alzheimer's Association monitors the scientific advances of the Association's grant awardees by maintaining records of publications, presentations, and intellectual property that result from funded studies. The Association requires the grant recipient to notify the Alzheimer's Association on an annual basis with updates to these records. Follow-on funding from federal agencies is also monitored. X true true X X X X X true true false false false false false false false Harry Johns President & CEO 617570 36360 130000 0 1315 0 245500 0 20428 0 1014813 36360 0 0 Richard Hovland COO/CFO 301882 502 90003 0 102270 0 63417 0 30957 0 588529 502 100000 0 Angela Geiger Chief Strategy Officer 366950 1444 106250 0 306 0 78050 0 22505 0 574061 1444 0 0 Maria Carrillo VP Med & Scientific Relations 259380 0 57500 0 252 0 28050 0 5074 0 350256 0 0 0 Robert Egge VP - Public Policy 251395 18760 64128 0 272 0 28050 0 27567 0 371412 18760 0 0 Scott Gardner VP - Chapter Relations 223473 294 52868 0 911 0 28000 0 12297 0 317549 294 0 0 Paula Pelissero Sr. Director, Human Resources 77596 0 0 0 146305 0 7583 0 920 0 232404 0 0 0 Donna McCullough VP - Mass Market & Corp Dev 247024 0 27827 0 834 0 12295 0 21489 0 309469 0 0 0 SCHEDULE J, PART I, LINE 1A TRAVEL FOR COMPANIONS At times a board member with early on-set Alzheimer's disease may require a companion to accompany him or her on business travel for safety reasons. Since his or her involvement in the meetings is critical to representing key constituents and appropriately fulfilling the mission of the Alzheimer's Association, the expenses of companion travel are reimbursed. SCHEDULE J, PART I, LINE 4A Severance Payment Due to a confidentiality agreement, neither the name nor the amount is being reported on the Alzheimer's Association Form 990, however, amounts were reported as taxable to the employee and reported on the individual's W-2. SCHEDULE J, PART I, LINE 4B SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN Harry Johns participates in a 457(f) supplemental non-qualified deferred compensation or retirement plan. The accrual amount under the plan in calendar year 2013 was $150,000. The accrual is part of a multi-year benefit which will become vested in 2017. In addition, Richard Hovland, Angela Geiger, and Harry Johns also participated in a 457(b) retirement plan. The amount accrued in calendar year 2013 is included on Schedule J as deferred compensation (i.e., Schedule J, Part II, column (c)). Harry Johns was the only individual in calendar year 2013 with an amount accrued under the provisions of the plan during the reporting period. The amount accrued for Harry Johns under this plan in calendar year 2013 was $17,500, which is the IRC prescribed maximum under this type of plan for the calendar year 2013. SCHEDULE J, PART II, COLUMN (B) (II) SUPPLEMENTAL COMPENSATION INFORMATION Harry Johns received performance based incentive compensation of $130,000 based on his successful achievement of specific goals, which were developed, reviewed, and approved by the Compensation Committee of the Board of Directors in consultation with the Board's independent third-party compensation consultants. This performance based incentive compensation was earned for performance in fiscal year 2013 and was paid in calendar year 2013. SCHEDULE J, PART II, COLUMN (B) (III) SUPPLEMENTAL COMPENSATION INFORMATION: OTHER REPORTABLE COMPENSATION Harry Johns, Angela Geiger, and Richard Hovland all receive a basic life insurance benefit of one times the annual salary. The amount represented in this section is imputed income for the group term life benefit. Robert Egge, Maria Carrillo, Donna McCullough, Scott Gardner, and Paula Pelissero also receive the life insurance benefit. Richard Hovland and Donna McCullough have additional imputed income for voluntary elections under the group disability plan. Richard Hovland - A retention incentive award in the amount of $100,000 was paid to Mr. Hovland in July 2013, which was tied to a multi-year vesting requirement through July 1, 2013. Since the vesting requirements were satisfied they required immediate taxation and distribution in 2013. It is important to note that most of the entire amount currently taxed and distributed has been previously reported as deferred compensation on prior 990's as indicated in Schedule J, Part II, Column (f). SCHEDULE J, PART II, COLUMN (C) SUPPLEMENTAL COMPENSATION INFORMATION Harry Johns - Retirement and other deferred compensation of $245,500 is comprised of the following: - Employer contributions to the qualified broad-based 401(k) retirement plan - $28,000; - Employer accrual of retirement benefit to a supplemental retirement account under the previously discussed 457(b) - $17,500; - Employer accrual of retirement benefit to a supplemental retirement account under the previously discussed 457(f) - $150,000; - Multi-year retention incentive - $40,000, accrued with vesting occurring on June 30, 2017. Richard Hovland - Retirement and other deferred compensation include employer contributions to a qualified 401(k) plan. In addition, a retention incentive award was paid to Mr. Hovland in July 2013, which was a benefit tied to specific multi-year vesting requirements through July 1, 2013 (i.e., Schedule J, Part II, column (c)). Angela Geiger - Retirement and other deferred compensation includes employer contribution to a qualified 401(k) retirement plan and a retention incentive accrual which was not paid as of December 31, 2013 but which is tied to specific multi-year vesting requirements through June 30, 2017. Robert Egge, Maria Carrillo, Donna McCullough, Scott Gardner, and Paula Pelissero - Retirement and other deferred compensation include employer contributions to a qualified 401(k) retirement plan. SCHEDULE J, PART II, COLUMN (D) SUPPLEMENTAL COMPENSATION INFORMATION Harry Johns - Non-taxable benefits of $20,428 include employer contributions to medical, dental, basic life insurance, short and long-term disability, and long term care insurance based on his personal elections for calendar year 2013 through the benefit offerings available to all other benefits-eligible employees at our organization. The amounts represented for Richard Hovland, Angela Geiger, Robert Egge, Maria Carrillo, Donna McCullough, Scott Gardner and Paula Pelissero represent company contributions to the medical, dental, basic life insurance, short and long term disability, and long term care insurances based on individual elections. X 517 212137 Cost/Selling Price X 149 4359713 Cost/Selling Price X Various noncash items 121 116658 Fair Market Value X Group Various Noncash Items 105 112696 Fair Market Value X Gala Noncash items 280 423962 Fair Market Value false true true SCHEDULE M, PART I, LINE 25 AND LINE 32B THIRD PARTY ASSISTANCE OF NONCASH CONTRIBUTIONS Line 25 - The Alzheimer's Association receives various noncash contributions for their fundraising events. These items include sporting tickets, jewelry, concert tickets, dinners and various other packages. Line 32B: A third party receives directly, sells and remits proceeds from automobile sales. FORM 990, Part III, Line 4d OTHER PROGRAM SERVICES Advocacy - As Alzheimer's disease threatens to bankrupt families, businesses and our healthcare system, scientists are moving closer to finding better treatments that could alter the course of the disease. The Alzheimer's Association advocates for public policies aimed at advancing research toward better therapies, detection, methods of prevention and ultimately a cure, as well as for better care and resources, and health and long-term coverage to ensure high quality cost effective care for people with Alzheimer's disease and their families. More than 600,000 grass roots advocates speak up for the needs and rights of people with Alzheimer's and their families, and encourage Congress to increase funding for research and care. Advocacy activities also include collaborating with other organizations to improve quality care and raise awareness of key issues. Expenses: 8,333,533 Grants: 1,293,648 Revenues: NONE Patient and Family Services - The Alzheimer's Association* provides an array of information and support services designed specifically for individuals with Alzheimer's disease, their families, friends and caregivers. In order to meet the diverse needs of individuals affected by Alzheimer's disease, the Association's programs and services are offered in person, by phone and online. Through programs and services, the Association provided more than 1.3 million service contacts to individuals in person or by telephone, and millions more online each year. Online and in chapters throughout the country, constituents can attend education programs and support groups, receive personalized care consultation, engage in early stage programs, enroll in support programs and purchase products to reduce the risks associated with wandering. In order to meet the needs of constituents who rely on the web for information and support, the Association offers a robust Caregiver Center. Within the Caregiver Center, families and caregivers can access Alzheimer's Navigator*, an innovative tool to help caregivers and people with dementia evaluate their needs, create a customized action plan and link to information, support and local resources for individuals living with Alzheimer's. Also available through the Caregiver Center, for individuals looking for support from others living in similar situations is ALZConnected*, this provides multiple forums and message boards within an active social networking community. Through the Association's helpline, available 24 hours a day, 7 days a week, 365 days a year, individuals with Alzheimer's disease and their families can talk to a specialist to receive information and basic education about the disease; and guidance for more complicated or urgent situations, Masters-level counselors are available to constituents, any time, day or night. Additionally, calls can be handled in over 170 different languages through the use of a professional language line. Annually, the Helpline receives more than 290,000 calls. The Association's website (www.alz.org) receives an average of 1.8 million visits each month. Online programs include: self-service education programs, an online community, an interactive brain tour (available in 15 languages), access to comprehensive disease information, portals in Spanish, Chinese, and Vietnamese, a virtual library, a safety center, and a newly developed microsite specifically for people living with Alzheimer's, with input from people in the early stages of Alzheimer's disease and their care partners. Through the Association's Early Stage Initiative, individuals in the early stages of the disease can participate in education programs, support groups and engagement programs. Additionally, the Association convenes an Early Stage Advisory Group whose members raise awareness, advocate for the cause, and provide guidance and review of programs and services. The programs and services of the Alzheimer's Association are designed to provide education, information, support, and resources in order to help individuals with Alzheimer's and their families navigate the long and complicated journey through Alzheimer's disease. * These are names that are trademarks of the Alzheimer's Association. Expenses: 18,612,684 Grants: 162,891 Revenues: NONE Form 990, Part VI, Line 1a GOVERNING BODY The Board of Directors of the Alzheimer's Association is the organization's governing body. The Board has delegated authority to its standing and other business committees as described in Article VII of the organizational bylaws. The following excerpt from the Association's bylaws discuss committees of the Board of Directors. Committees of Directors: The Board of Directors shall have the following standing committees: Executive, Finance, Governance and Nominating, Compensation and Audit. Executive Committee: The Executive Committee shall supervise the affairs of the Association, approve expenditures and commitments according to policies prescribed by the Board of Directors, act for and carry out the established policies of the Association as defined by the Board of Directors, including the policies and procedures, report to the Board of Directors at each meeting of the Board of Directors and have such other additional powers as may be by law or resolution of the Board of Directors provided. The Executive Committee shall have and may exercise all authority including the election of officers other than the Chair, Chair Elect, one or more vice Chairs, Secretary, Treasurer or President and Chief Executive Officer, it being understood that the Executive Committee may elect an interim President and Chief Executive Officer to serve until the next meeting of the Board of Directors in the management of the Association, subject to the limitations contained in the Delaware corporation law. The Committee's responsibilities shall include, but not be limited to, initiating long-range planning, environmental scanning and performance evaluation; initiating the Board's annual strategic priorities for approval by the Board; assisting the Chair in developing charges to the committees; identifying programmatic and financial indicators of Association performance; conducting the review, performance evaluation and succession planning for the President and CEO; making bylaw recommendations to the Board; reviewing the activities of the Medical and Scientific Advisory Council; and identifying significant issues as that term is defined in Article IX which require consideration by the Association Assembly as described in the same Article and receiving, on behalf of the Board, the Association Assembly's suggestions and recommendations for Board consideration or action. At each of its annual meetings, the Board of Directors by duly adopted resolution shall elect an Executive Committee consisting of not less than eleven or more than fifteen Directors. The Chair, Chair Elect, Vice Chairs, Secretary, Treasurer, Chairs of the Standing Committees and Chairs of the following Committees: Chapter Relations, Development, Diversity and Inclusion, Program, and Public Policy, as well as the Chair of the Medical and Scientific Advisory Council shall be members of the Executive Committee. The Chair of the Board of Directors shall be the Chair of the Executive Committee. The Executive Committee may hold regular meetings monthly or as it may otherwise determine, at such place and at such times and upon such notice as it may determine. Special meetings of the Executive Committee may be called at any time by the Chair or by any three of its members, by notice delivered personally or by mail, telephone, electronic mail or facsimile at least seven days (or at least 48 hours in the case of telephonic meetings) prior to the meeting. A majority of the currently serving members of the Executive Committee shall constitute a quorum for all purposes. Finance Committee: The Finance Committee shall consist of at least five Directors and shall be chaired by the Treasurer. The Finance Committee shall oversee and review all financial reports, accounting activities and investment decisions of the Association and also shall prepare a projected budget for each fiscal year to be presented to the Board of Directors for approval. Governance and Nominating Committee: At each of its annual meetings, the Board of Directors by duly adopted resolution shall elect a Governance and Nominating Committee consisting of not less than nine nor more than fifteen individuals currently serving as a Director. At least one-third of the Governance and Nominating Committee shall be Directors having chapter experience. The Governance and Nominating Committee shall assist the Board in ensuring the successful governance of the Association through board assessment, recruitment, nominations, orientation and development. The Governance and Nominating Committee shall nominate candidates for Directors, Officers and members of the Executive Committee. The Governance and Nominating Committee may nominate candidates for Director Emeritus, Honorary Director and any advisory or Honorary Councils or Committees and approve and present to the Board for approval the candidates for MSAC membership. The Governance and Nominating Committee also shall provide input to the Chair on the selection of Vice Chairs and Committee Chairs. Compensation Committee: A Compensation Committee which shall recommend salary and benefits for the President and CEO and Senior Officers of the Association; help ensure succession plans are in place for key positions in the Association and provide oversight on the retirement programs offered by the Association to its employees. Audit Committee: The Audit Committee shall be responsible for recommending an auditor to the Board of Directors and shall oversee the activities of any internal auditor of the Association. The Committee shall see that an annual audit is prepared by an independent firm of Certified Public Accountants selected by the Board of Directors and, upon receiving such auditor's report, the Committee shall preview the audit report for submission to the Board of Directors each year. The Committee shall review the financial reports of the Association, its system of internal controls, and the audit process, including the review of the activities of the Medical and Scientific Advisory Council. The Audit Committee shall have at least five members, all of whom are members of the Board of Directors and the majority of whom have appropriate financial expertise. At least one member of the Audit Committee shall meet the requirement of "Audit Committee Financial Expert" as then defined by the Securities and Exchange Commission. The majority of the members of the Audit Committee may not concurrently serve on the Finance Committee and the Treasurer and Chair of the Finance Committee may not serve concurrently on the Audit Committee. Other Committees: In addition to the standing committees, other committees may be designated by resolution adopted by a majority of the Directors present at any meeting. Other committees shall include, but not be limited to, the following business committees: A. A Chapter Relations Committee which shall recommend and monitor consistent, predictable and accountable Board Policy in affiliate relations. B. A Development Committee which shall advise the Board on philanthropic giving to the Association and recommend fundraising policies. C. A Program Committee which shall recommend for Board consideration and approval policy issues related to market and needs assessment, programs and services, quality and standards and related matters. D. A Public Policy Committee which shall provide guidance to the Board on federal, state and local public policy issues and strategies including research funding, health care, long term care, and publicly funded care and support programs. E. A Diversity & Inclusion Committee which shall help ensure that the Alzheimer's Association serves and reflects diverse communities, shall work with the National Board of Directors and other committees to foster diversity and inclusion with respect to the Association strategic plan and shall report on progress the Association and Board are making on achieving the Association's diversity and inclusion strategic goals. Form 990, Part VI, Line 11b FORM 990 REVIEW PROCESS The Organization undergoes a thorough review process before filing the return. The audit committee discusses and reviews the form before it is provided to the officers and full Board of Directors. All officers and the full Board of Directors are provided a copy for their review and have the opportunity to comment before the form is filed. Form 990, Part VI, Line 12c CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT The Alzheimer's Association conflict of interest policy is described in Article XVII, Section 2 of the organizational bylaws. The responsibility for disclosing any known or reasonably foreseen actual or potential conflicts of interest shall be upon the interested party whose interests are or may appear to be in conflict with the Association. All interested parties are required to file with the Association a disclosure statement prior to such individual commencing his or her service with the Association and thereafter shall file with the Association an updated disclosure statement as may be required from time to time by the Board of Directors or its Committee designee and in no event less often than annually. As cited from Article XVII, Section 2 of the bylaws, interested persons or Chapters shall disclose any conflict and shall not vote on a matter and further if requested by the chair or resolution of the board shall leave the room in which the Board or committee is meeting and shall not participate in any deliberation or decision regarding the matter under consideration. The minutes shall reflect that the conflict of interest was disclosed and the interested person or Chapter representative did not participate in any discussion of the matter and did not vote on the matter in person or by proxy. When any such conflict of interest is relevant to a matter requiring action by the Board of Directors or any committee of the Board, the interested person or Chapter shall disclose such conflict to the Board of Directors or such committee and shall not vote on the matter. Further the interested person or representative from a Chapter having a conflict if requested by the chair or resolution of the board shall leave the room in which the Board or the committee is meeting and shall not participate in any deliberation or decision regarding the matter under consideration. When there is a doubt as to whether a conflict of interest exists, the matter shall be resolved by a vote of the Board of Directors or the committee, as the case may be, excluding the interested person or representative from a chapter concerning whom the doubt has arisen. The Governance and Nominating Committee of the Board of Directors shall report to the Board of Directors from time to time on the implementation of these guidelines and the status of any policy developments regarding compensation and conflicts of interest. Copies of the Alzheimer's Association bylaws, including the conflict of interest policy, are provided to all Board Directors no less than annually. Board Director disclosure statements are submitted no less than annually. Potential conflicts disclosed by Board Directors or candidates for election to the board are reviewed by the Governance and Nominating Committee, which reports no less than annually on its review to the full board. As documented in the meeting minutes, at the start of each meeting of the Board of Directors as well as each meeting of the executive committee, the agenda is reviewed and all Directors in attendance are reminded of the Conflict of Interest Policy and advised to disclose any potential conflicts should they exist or arise. Form 990, Part VI, Line 15a & 15b PROCESS FOR DETERMINING COMPENSATION COMPENSATION IS ESTABLISHED FOR THE CEO BY THE COMPENSATION COMMITTEE AND THE EXECUTIVE COMMITTEE AFTER A THOROUGH SALARY/MARKET REVIEW CONDUCTED BY OUTSIDE CONSULTANTS. FOR THE CEO position, the gathering of relevant comparability data from independent sources occurred in 2013. The process was conducted in a manner intended to qualify for the rebuttable presumption of reasonableness under the intermediate sanctions rules. As to the members of the senior management team other than the CEO, annually updated market data also is provided by the outside compensation consultant, so that the updated market data can be used in setting reasonable compensation for each member of the senior management team. Each year the Compensation Committee evaluates the CEO's performance through a robust assessment process which includes 360 feedback collection, interviews and performance evaluation comparing results to goals. The Committee and Chair of the Board use this data to determine incentive compensation eligibility. The senior staff has a comprehensive performance evaluation and compensation review done at the end of each fiscal year. These include a self-assessment, 360 review and evaluation by the CEO. Updated market data for use in setting reasonable compensation is provided by a national compensation consulting firm to the Compensation Committee for confirmation of reasonableness using a process designed to qualify for the rebuttable presumption of reasonableness (including contemporaneous documentation in the Committee's minutes). For this year the salaries and total compensation packages of the senior staff were benchmarked by AonHewitt. Compensation is contemporaneously documented in the Compensation Committee minutes. FORM 990, Part VI, Section C, Line 18 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC The organization makes its Form 990 available to the general public by posting on the website at www.alz.org and upon request. The organization makes its Form 1023 available to the general public upon request. FORM 990, Part VI, Section C, Line 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC The organization's audited financial statements are made available to the general public by posting on the organization's website at www.alz.org and upon request. The organization makes its governing documents and conflict of interest policy available to the general public upon request. Form 990, Part XI, Line 9 OTHER CHANGE IN NET ASSETS OR FUND BALANCE CHANGE IN PERPETUAL TRUST $1,548,279 Change in split interest -253,845 Acquisition of dissolved chapters 6,163,489 Bad Debt -520,386 TOTAL $6,937,537 Alzheimer's Impact Movement (AIM) 225 North Michigan Ave Suite 1700 Chicago IL 60601 271961435 Soc Welfare IL 501c4 Alz Assoc true false true false false false false false false false false false false false true true false false false false Alzheimer's Impact Movement b 1043725 FMV Alzheimer's Impact Movement o 57060 FMV Schedule R, Part V, Line 2 AMOUNT INVOLVED IN RELATIONSHIP The Alzheimer's Association granted funds to Alzheimer's Impact Movement (AIM) for public policy division activities in fiscal year 2014 to support priorities identified in the Alzheimer's Association's strategic plan. This grant is restricted to the following 501(c)3 activities and the ancillary activities necessary to accomplish specific goals including: Implementation of the National Alzheimer's Project Act: Recognizing this growing Alzheimer's crisis, Congress unanimously passed and President Obama signed into law the National Alzheimer's Project Act (NAPA); increasing the commitment to Alzheimer's research; expanding education efforts and caregiver support services; expanding diagnosis and planning.